Major cardiovascular outcomes trial. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cardiovascular System Brachial Artery Tunica Media Tunica Intima Endothelium, Vascular Carotid Arteries Kidney Aorta

Diseases49

Cardiovascular Diseases Hypertension Coronary Disease Myocardial Infarction Stroke Coronary Artery Disease Kidney Failure, Chronic Diabetes Mellitus, Type 2 White Coat Hypertension Acute Coronary Syndrome Diabetes Complications Heart Failure Kidney Diseases Recurrence Disease Progression Renal Insufficiency, Chronic Diabetic Angiopathies Chronic Disease Diabetic Nephropathies Asymptomatic Diseases Peripheral Arterial Disease Atherosclerosis Postoperative Complications Diabetes Mellitus Peripheral Vascular Diseases Acute Disease Renal Insufficiency Dyslipidemias Death, Sudden, Cardiac Albuminuria Ventricular Dysfunction, Left Angina, Unstable Atrial Fibrillation Obesity Heart Diseases Angina Pectoris Hypertrophy, Left Ventricular Myocardial Ischemia Calcinosis Metabolic Syndrome X Proteinuria Inflammation Neoplasms Carotid Artery Diseases Breast Neoplasms Pregnancy Complications Neoplasm Recurrence, Local HIV Infections Pain

Chemicals and Drugs44

Amlodipine Antihypertensive Agents Atenolol Heptanoic Acids Hydroxymethylglutaryl-CoA Reductase Inhibitors Anticholesteremic Agents Pyrroles Biological Markers Hypoglycemic Agents Angiotensin II Type 1 Receptor Blockers Ticlopidine Platelet Aggregation Inhibitors Dipeptidyl-Peptidase IV Inhibitors Cardiovascular Agents Tetrazoles Angiotensin-Converting Enzyme Inhibitors Perindopril C-Reactive Protein Pravastatin Ramipril Adrenergic beta-Antagonists Particulate Matter Blood Glucose Hemoglobin A, Glycosylated Hypolipidemic Agents Thiazolidinediones Calcium Channel Blockers Aspirin Creatinine Diuretics Metformin Cholesterol, LDL Benzimidazoles Verapamil Placebos Natriuretic Peptide, Brain Cardiotonic Agents Lipids Cholesterol, HDL Antineoplastic Agents Peptide Fragments Triglycerides Fibrinolytic Agents Anti-Bacterial Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Treatment Outcome Randomized Controlled Trials as Topic Clinical Trials as Topic Drug Therapy, Combination Risk Factors Follow-Up Studies Prospective Studies Prognosis Risk Assessment Proportional Hazards Models Cohort Studies Double-Blind Method Retrospective Studies Predictive Value of Tests Kaplan-Meier Estimate Renal Dialysis Pregnancy Outcome Blood Pressure Research Design Severity of Illness Index Survival Rate Survival Analysis Incidence Multivariate Analysis Risk Glomerular Filtration Rate Chi-Square Distribution Hospitalization Logistic Models Clinical Trials, Phase III as Topic Longitudinal Studies Regression Analysis Prevalence Blood Pressure Monitoring, Ambulatory Registries Cause of Death Morbidity Angioplasty, Balloon, Coronary Clinical Trials, Phase II as Topic Odds Ratio Controlled Clinical Trials as Topic Cross-Sectional Studies Clinical Trials, Phase I as Topic Coronary Artery Bypass Patient Selection Case-Control Studies Heart Rate Clinical Protocols Analysis of Variance Disease-Free Survival Blood Pressure Determination Single-Blind Method Stents Linear Models Kidney Function Tests Obesity Myocardial Revascularization Sensitivity and Specificity Coronary Angiography Placebos Ankle Brachial Index Electrocardiography Multicenter Studies as Topic Body Mass Index Combined Modality Therapy Pilot Projects Stroke Volume Glasgow Outcome Scale Early Termination of Clinical Trials Antineoplastic Combined Chemotherapy Protocols Length of Stay Questionnaires Reproducibility of Results Pain Measurement Sample Size Reference Values Feasibility Studies Echocardiography Treatment Failure Exercise Therapy Disability Evaluation Neoplasm Staging Drug Administration Schedule Hospital Mortality Data Interpretation, Statistical Statistics, Nonparametric Administration, Oral Program Evaluation Activities of Daily Living Cross-Over Studies Magnetic Resonance Imaging Reoperation Clinical Trials, Phase IV as Topic Confidence Intervals Random Allocation Meta-Analysis as Topic Chemotherapy, Adjuvant Physical Therapy Modalities Tomography, X-Ray Computed Probability Infusions, Intravenous Models, Statistical

Psychiatry and Psychology7

Risk Reduction Behavior Medication Adherence Patient Compliance Cognitive Therapy Pain Depression Decision Making

Phenomena and Processes26

Time Factors Pregnancy Outcome Blood Pressure Risk Glomerular Filtration Rate Chi-Square Distribution Odds Ratio Pregnancy Heart Rate Genotype Obesity Sensitivity and Specificity Renin-Angiotensin System Body Mass Index Stroke Volume Pulsatile Flow Ventricular Function, Left Recovery of Function Systole Polymorphism, Single Nucleotide Diastole Circadian Rhythm Polymorphism, Genetic Dose-Response Relationship, Drug Pain Probability

Disciplines and Occupations4

Outcome Assessment (Health Care)Research Design Pharmacogenetics Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life Patient Education as Topic Activities of Daily Living Health Status

Technology, Industry, Agriculture1

Dietary Supplements

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Prevalence Registries Cause of Death Morbidity Databases, Factual Glasgow Outcome Scale Questionnaires Hospital Mortality Data Interpretation, Statistical

Named Groups2

Infant, Newborn European Continental Ancestry Group

Health Care85

Treatment Outcome Randomized Controlled Trials as Topic Clinical Trials as Topic Risk Factors Follow-Up Studies Outcome Assessment (Health Care)Prospective Studies Risk Assessment Proportional Hazards Models Cohort Studies Double-Blind Method Retrospective Studies Predictive Value of Tests Kaplan-Meier Estimate Severity of Illness Index Survival Rate Survival Analysis Incidence Multivariate Analysis Risk Age Factors Chi-Square Distribution Hospitalization Logistic Models Outcome and Process Assessment (Health Care)Clinical Trials, Phase III as Topic Longitudinal Studies Regression Analysis Prevalence Registries Cause of Death Morbidity Secondary Prevention Sex Factors Clinical Trials, Phase II as Topic Odds Ratio Controlled Clinical Trials as Topic Cross-Sectional Studies Clinical Trials, Phase I as Topic Patient Selection Case-Control Studies Comorbidity Clinical Protocols Analysis of Variance Disease-Free Survival Single-Blind Method Linear Models Practice Guidelines as Topic Sensitivity and Specificity Multicenter Studies as Topic Cost-Benefit Analysis Body Mass Index Pilot Projects Medication Adherence Patient Satisfaction Glasgow Outcome Scale Early Termination of Clinical Trials Length of Stay Patient Compliance Questionnaires Reproducibility of Results Sample Size Feasibility Studies Clinical Trials Data Monitoring Committees Treatment Failure Patient Outcome Assessment Hospital Mortality Data Interpretation, Statistical Patient Education as Topic Statistics, Nonparametric Intention to Treat Analysis Program Evaluation Activities of Daily Living Cross-Over Studies Health Status Clinical Trials, Phase IV as Topic Health Care Costs Confidence Intervals Random Allocation Meta-Analysis as Topic Primary Health Care Bias (Epidemiology)Probability Models, Statistical Placebo Effect

Geographicals6

United States Japan Great Britain Netherlands England Canada

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Amlodipine Treatment Outcome Cardiovascular Diseases Antihypertensive Agents Atenolol Hypertension Heptanoic Acids Hydroxymethylglutaryl-CoA Reductase Inhibitors Anticholesteremic Agents Randomized Controlled Trials as Topic Pyrroles Clinical Trials as Topic Drug Therapy, Combination Risk Factors Follow-Up Studies Outcome Assessment (Health Care)Coronary Disease Prospective Studies Myocardial Infarction Prognosis Stroke Time Factors Risk Assessment Proportional Hazards Models Cohort Studies Double-Blind Method Retrospective Studies Predictive Value of Tests Coronary Artery Disease Kidney Failure, Chronic Diabetes Mellitus, Type 2 White Coat Hypertension Kaplan-Meier Estimate Biological Markers Renal Dialysis Pregnancy Outcome Blood Pressure Hypoglycemic Agents Research Design Acute Coronary Syndrome Severity of Illness Index Diabetes Complications Survival Rate Survival Analysis Heart Failure United States Incidence Angiotensin II Type 1 Receptor Blockers Multivariate Analysis Risk Ticlopidine Kidney Diseases Cardiovascular System Glomerular Filtration Rate Platelet Aggregation Inhibitors Dipeptidyl-Peptidase IV Inhibitors Pharmacogenetics Recurrence Age Factors Cardiovascular Agents Disease Progression Tetrazoles Chi-Square Distribution Angiotensin-Converting Enzyme Inhibitors Hospitalization Logistic Models Renal Insufficiency, Chronic Outcome and Process Assessment (Health Care)Diabetic Angiopathies Chronic Disease Clinical Trials, Phase III as Topic Diabetic Nephropathies Longitudinal Studies Perindopril Regression Analysis Asymptomatic Diseases C-Reactive Protein Peripheral Arterial Disease Evidence-Based Medicine Prevalence Atherosclerosis Postoperative Complications Blood Pressure Monitoring, Ambulatory Registries Cause of Death Diabetes Mellitus Morbidity Pravastatin Ramipril Secondary Prevention Sex Factors Angioplasty, Balloon, Coronary Adrenergic beta-Antagonists Clinical Trials, Phase II as Topic Dietary Supplements Odds Ratio Controlled Clinical Trials as Topic Peripheral Vascular Diseases Cross-Sectional Studies Particulate Matter

No FAQ available that match "major cardiovascular outcomes trial"